-
公开(公告)号:US20100178292A1
公开(公告)日:2010-07-15
申请号:US12686102
申请日:2010-01-12
IPC分类号: A61K39/395 , C07H3/06 , C07K16/30 , C07K16/00 , C07K19/00 , A61P35/00 , C12N9/96 , C12N5/00 , G01N33/53 , C40B40/12 , C40B30/04
CPC分类号: C07H3/00 , A61K2039/505 , C07K14/525 , C07K16/30 , C07K16/3084 , C40B40/12 , G01N33/5091 , G01N33/57492 , G01N2400/12
摘要: The present invention relates to a novel glycan marker of cancer and monoclonal antibodies against it. Furthermore, novel glycan markers and their use in the detection and monitoring of cancerous cells and cancer-associated or specific antibody signatures are described.
摘要翻译: 本发明涉及抗癌的新型聚糖标记物和针对其的单克隆抗体。 此外,描述了新的聚糖标记及其在检测和监测癌细胞和癌症相关或特异性抗体特征中的用途。